by David Kent | Jun 16, 2015
. Last week the German Stem Cell Network (SCN) released three videos on the current and future possibilities of stem cells. The videos feature three top tier scientists in the field – Andreas Trumpp, Magdalena Gotz and Anthony Ho – and treat viewers to their...
by Mark Curtis | May 27, 2015
. Welcome to your deal review for the month of April. There is no update yet on the fate of the Cellular Dynamics International/Fujifilm deal, but it appears that CDI made some effort to solicit offers from alternative bidders. Aduro made headlines, though, closing a...
by Mark Curtis | May 25, 2015
. Welcome to your Update from the Clinic for the month of April. Mesenchymal stem cells took a hit as Athersys’ MultiStem came up short, missing its primary endpoint in a Phase 2 study investigating the cells for ischemic stroke. Juno Therapeutics continues to turn...
by Paul Krzyzanowski | May 21, 2015
. By now, many of you will have heard of Fujifilm’s USD$307 million purchase of Cellullar Dynamics International (CDI). This may seem like a major entry into the regenerative medicine (RM) space for a company that’s better known for its imaging technologies than...
by David Kent | Apr 16, 2015
. Last month, Nature published a comment by Edward Lanphier and colleagues, which foreshadows the publication of a study in which scientists have used new genome editing tools to modify the DNA of human embryos. Author David Cyranoski weighed in, suggesting that...
by Mark Curtis | Apr 13, 2015
. Welcome to your deal review for the month of March. Cellular Dynamics threw shareholders for a loop after making a seemingly hasty decision to sell the company off to Fujifilm in a $307* million deal. Merck and synthetic biology specialist Intrexon announced a...
Comments